Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned.

IARC scientific publications

Volumn 154, Issue , 2001, Pages 49-55

  Meyskens Jr , F L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BOWMAN BIRK INHIBITOR; EFLORNITHINE; TRYPSIN INHIBITOR; TUMOR MARKER;

COLON TUMOR; DRUG SCREENING; HUMAN; METHODOLOGY; MOUTH TUMOR; REVIEW; RISK;

ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DRUG EVALUATION; EFLORNITHINE; HUMANS; MOUTH NEOPLASMS; RISK; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN; TRYPSIN INHIBITORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035236512     PISSN: 03005038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)